Showing results 1 to 20 of 22
next >
Issue Date | Title | Author(s) |
2023-03-20 | Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance. | Scaramuzzo, G; Nucera, F; Asmundo, A; Messina, R; Mari, M; Montanaro, F; Johansen, MD; Monaco, F; Fadda, G; Tuccari, G; Hansbro, NG; Hansbro, PM; Hansel, TT; Adcock, IM; David, A; Kirkham, P; Caramori, G; Volta, CA; Spadaro, S |
2022-11-23 | Association of Differential Mast Cell Activation to Granulocytic Inflammation in Severe Asthma. | Tiotiu, A; Badi, Y; Kermani, NZ; Sanak, M; Kolmert, J; Wheelock, CE; Hansbro, PM; Dahlén, S-E; Sterk, PJ; Djukanovic, R; Guo, Y; Mumby, S; Adcock, IM; Chung, KF; U-BIOPRED consortium project team, |
2022-07-01 | Adverse roles of mast cell chymase-1 in chronic obstructive pulmonary disease. | Liu, G; Jarnicki, AG; Paudel, KR; Lu, W; Wadhwa, R; Philp, AM; Van Eeckhoutte, H; Marshall, JE; Malyla, V; Katsifis, A; Fricker, M; Hansbro, NG; Dua, K; Kermani, NZ; Eapen, MS; Tiotiu, A; Chung, KF; Caramori, G; Bracke, K; Adcock, IM; Sohal, SS; Wark, PA; Oliver, BG; Hansbro, PM |
2022-01-01 | Chapter 14 Role of autoimmunity in the pathogenesis of chronic obstructive pulmonary disease and pulmonary emphysema | Nucera, F; Hansbro, PM; Casolaro, V; Appanna, R; Kirkham, P; Adcock, IM; Caramori, G |
2021-10-26 | Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways. | Aliee, H; Massip, F; Qi, C; Stella de Biase, M; van Nijnatten, J; Kersten, ETG; Kermani, NZ; Khuder, B; Vonk, JM; Vermeulen, RCH; U-BIOPRED study group,; Cambridge Lung Cancer Early Detection Programme,; INER-Ciencias Mexican Lung Program,; Neighbors, M; Tew, GW; Grimbaldeston, MA; Ten Hacken, NHT; Hu, S; Guo, Y; Zhang, X; Sun, K; Hiemstra, PS; Ponder, BA; Mäkelä, MJ; Malmström, K; Rintoul, RC; Reyfman, PA; Theis, FJ; Brandsma, C-A; Adcock, IM; Timens, W; Xu, C-J; van den Berge, M; Schwarz, RF; Koppelman, GH; Nawijn, MC; Faiz, A |
2021-10-19 | Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. | Pinkerton, JW; Kim, RY; Brown, AC; Rae, BE; Donovan, C; Mayall, JR; Carroll, OR; Khadem Ali, M; Scott, HA; Berthon, BS; Baines, KJ; Starkey, MR; Kermani, NZ; Guo, Y-K; Robertson, AAB; O'Neill, LAJ; Adcock, IM; Cooper, MA; Gibson, PG; Wood, LG; Hansbro, PM; Horvat, JC |
2020-09-29 | New drugs under development for COPD. | Lo Bello, F; Hansbro, PM; Donovan, C; Coppolino, I; Mumby, S; Adcock, IM; Caramori, G |
2020-08-20 | Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. | Gosens, R; Hiemstra, PS; Adcock, IM; Bracke, KR; Dickson, RP; Hansbro, PM; Krauss-Etschmann, S; Smits, HH; Stassen, FRM; Bartel, S |
2020-08-19 | Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD | Nucera, F; Lo Bello, F; Shen, SS; Ruggeri, P; Coppolino, I; Di Stefano, A; Stellato, C; Casolaro, V; Hansbro, PM; Adcock, IM; Caramori, G |
2020-04-23 | Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma. | Ali, MK; Kim, RY; Brown, AC; Mayall, JR; Karim, R; Pinkerton, JW; Liu, G; Martin, KL; Starkey, MR; Pillar, AL; Donovan, C; Pathinayake, PS; Carroll, OR; Trinder, D; Tay, HL; Badi, YE; Kermani, NZ; Guo, Y-K; Aryal, R; Mumby, S; Pavlidis, S; Adcock, IM; Weaver, J; Xenaki, D; Oliver, BG; Holliday, EG; Foster, PS; Wark, PA; Johnstone, DM; Milward, EA; Hansbro, PM; Horvat, JC |
2020-03-19 | Role of the mucins in pathogenesis of COPD: implications for therapy. | Lo Bello, F; Ieni, A; Hansbro, PM; Ruggeri, P; Di Stefano, A; Nucera, F; Coppolino, I; Monaco, F; Tuccari, G; Adcock, IM; Caramori, G |
2019-12 | "Cellular mechanisms underlying steroid-resistant asthma." Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021. | Wadhwa, R; Dua, K; Adcock, IM; Horvat, JC; Kim, RY; Hansbro, PM |
2019-10-01 | Functional effects of the microbiota in chronic respiratory disease | Budden, KF; Shukla, SD; Rehman, SF; Bowerman, KL; Keely, S; Hugenholtz, P; Armstrong-James, DPH; Adcock, IM; Chotirmall, SH; Chung, KF; Hansbro, PM |
2019-09-01 | Cellular mechanisms underlying steroid-resistant asthma | Wadhwa, R; Dua, K; Adcock, IM; Horvat, JC; Kim, RY; Hansbro, PM |
2019-07-01 | IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis | Starkey, MR; Plank, MW; Casolari, P; Papi, A; Pavlidis, S; Guo, Y; Cameron, GJM; Haw, TJ; Tam, A; Obiedat, M; Donovan, C; Hansbro, NG; Nguyen, DH; Nair, PM; Kim, RY; Horvat, JC; Kaiko, GE; Durum, SK; Wark, PA; Sin, DD; Caramori, G; Adcock, IM; Foster, PS; Hansbro, PM |
2019-06-03 | Molecular links between COPD and lung cancer: new targets for drug discovery? | Caramori, G; Ruggeri, P; Mumby, S; Ieni, A; Lo Bello, F; Chaminka, V; Donovan, C; Andò, F; Nucera, F; Coppolino, I; Tuccari, G; Hansbro, PM; Adcock, IM |
2018-02-01 | Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease | Haw, TJ; Starkey, MR; Pavlidis, S; Fricker, M; Arthurs, AL; Nair, PM; Liu, G; Hanish, I; Kim, RY; Foster, PS; Horvat, JC; Adcock, IM; Hansbro, PM |
2017-12-31 | Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma? | Ng Kee Kwong, F; Nicholson, AG; Harrison, CL; Hansbro, PM; Adcock, IM; Chung, KF |
2017-02-01 | MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2 | Kim, RY; Horvat, JC; Pinkerton, JW; Starkey, MR; Essilfie, AT; Mayall, JR; Nair, PM; Hansbro, NG; Jones, B; Haw, TJ; Sunkara, KP; Nguyen, TH; Jarnicki, AG; Keely, S; Mattes, J; Adcock, IM; Foster, PS; Hansbro, PM |
2017-01-01 | Animal models of COPD: What do they tell us? | Jones, B; Donovan, C; Liu, G; Gomez, HM; Chimankar, V; Harrison, CL; Wiegman, CH; Adcock, IM; Knight, DA; Hirota, JA; Hansbro, PM |